Search clinical trials for: Envarsus
Total 66 results
-
Edward GeisslerChiesi Pharmaceuticals GmbHRecruiting
-
University Hospital, EssenRecruitingPediatric Kidney DiseaseGermany
-
University Health Network, TorontoPaladin Labs Inc.Not yet recruitingLiver Transplant Rejection | Immune System Suppression
-
Medical College of WisconsinRecruitingGraft-versus-host DiseaseUnited States
-
University of AlbertaRecruitingCardiovascular Diseases | Renal Insufficiency | Metabolic Syndrome | Liver Transplant; Complications | Immunosuppressant Adverse ReactionCanada
-
Leiden University Medical CenterRecruitingAutoimmune HepatitisNetherlands
-
University of British ColumbiaPaladin Labs Inc.RecruitingLiver Transplantation | Neurotoxicity | Tremor | Tacrolimus | ImmunosuppressionCanada
-
Nantes University HospitalRecruitingRenal Transplant FailureFrance
-
Vanderbilt University Medical CenterVeloxis PharmaceuticalsRecruitingRenal TransplantUnited States
-
University of Southern CaliforniaVeloxis PharmaceuticalsRecruitingKidney Transplantation | Kidney Transplant RejectionUnited States
-
Beth Israel Deaconess Medical CenterVeloxis PharmaceuticalsNot yet recruitingMedication Adherence | Renal Transplant
-
Roy D. Bloom, MDVeloxis PharmaceuticalsRecruitingKidney Transplant; ComplicationsUnited States
-
University of Wisconsin, MadisonVeloxis PharmaceuticalsRecruitingKidney Pancreas TransplantationUnited States
-
Imperial College LondonRecruitingImmunosuppression | Kidney Transplant Failure | AllosensitizationUnited Kingdom
-
Medical University of WarsawRecruitingImmunosuppression | Liver Transplant RejectionPoland
-
California Institute of Renal ResearchUniversity of California, San Diego; Balboa Institute of TransplantationRecruitingKidney Transplant; Complications | Kidney Transplant Failure and RejectionUnited States
-
Yale UniversityVeloxis PharmaceuticalsRecruitingKidney Transplant; ComplicationsUnited States
-
Roberto GedalyVeloxis PharmaceuticalsRecruitingEnd Stage Renal DiseaseUnited States
-
Dimitrios Tzachanis, MD PhDBristol-Myers SquibbActive, not recruitingHematologic Neoplasms | GVHDUnited States
-
Medical University of South CarolinaVeloxis PharmaceuticalsCompletedNeurotoxicity | Liver Transplant; ComplicationsUnited States
-
Sentara Norfolk General HospitalVeloxis PharmaceuticalsCompletedTransplant;Failure,KidneyUnited States
-
Edward GeisslerExcelya; Chiesi Pharmaceuticals GmbHActive, not recruitingProphylaxis Against Liver Transplant RejectionGermany
-
University Hospital TuebingenCompletedPosttransplant Diabetes MellitusGermany
-
Vanderbilt University Medical CenterVeloxis PharmaceuticalsEnrolling by invitationLung Transplant; ComplicationsUnited States
-
Nantes University HospitalChiesi Farmaceutici S.p.A.CompletedDiabetes | Kidney Transplantation | Pancreas TransplantationFrance
-
University of California, DavisVeloxis PharmaceuticalsCompletedToxicity | Neurotoxicity | Kidney Transplant; Complications | Drug ToxicityUnited States
-
Mayo ClinicVeloxis PharmaceuticalsActive, not recruitingKidney Transplant RecipientsUnited States
-
University of WashingtonNational Cancer Institute (NCI)TerminatedMetastatic Prostate Carcinoma | Prostate Adenocarcinoma | Stage IV Prostate Cancer AJCC v8 | Metastatic Malignant Neoplasm in the Bone | Stage IVA Prostate Cancer AJCC v8 | Stage IVB Prostate Cancer AJCC v8 | Prostate Small Cell Neuroendocrine Carcinoma | Castration-Sensitive Prostate CarcinomaUnited States
-
University of NebraskaNational Cancer Institute (NCI)CompletedLymphoma | Myelodysplastic Syndromes | Leukemia | Multiple Myeloma and Plasma Cell Neoplasm | Myelodysplastic/Myeloproliferative Diseases | Graft Versus Host Disease | Secondary MyelofibrosisUnited States
-
Cedars-Sinai Medical CenterVeloxis PharmaceuticalsActive, not recruitingKidney Transplant RejectionUnited States
-
University of Alabama at BirminghamCompletedRenal Transplant InfectionUnited States
-
University of Wisconsin, MadisonVeloxis PharmaceuticalsCompleted
-
Temple UniversityVeloxis PharmaceuticalsCompletedKidney TransplantUnited States
-
Lorenzo GallonCompletedEnd Stage Renal Disease | Rejection of Renal TransplantUnited States
-
University of California, Los AngelesVeloxis PharmaceuticalsActive, not recruitingKidney Transplantation | Renal Transplantation | Grafting, KidneyUnited States
-
Baylor Research InstituteActive, not recruitingCompliance, Patient | Graft Failure | Heart Transplant RejectionUnited States
-
University of Colorado, DenverCompleted
-
Barts & The London NHS TrustWithdrawnRenal Transplant FailureUnited Kingdom
-
Universitätsklinikum Hamburg-EppendorfCompletedLiver TransplantationGermany
-
University of Kansas Medical CenterVeloxis PharmaceuticalsCompletedEnd Stage Renal DiseaseUnited States
-
University of MinnesotaCompletedKidney Transplant Failure and RejectionUnited States
-
Columbia UniversityVeloxis PharmaceuticalsActive, not recruitingRenal Transplant Rejection | Kidney Transplant Failure and RejectionUnited States
-
Methodist HealthcareCompletedRecipients of Liver TransplantUnited States
-
Albert Einstein Healthcare NetworkVeloxis PharmaceuticalsActive, not recruitingPost Liver TransplantUnited States
-
The Methodist Hospital Research InstituteVeloxis PharmaceuticalsWithdrawnAcute Rejection of Renal Transplant | Kidney Disease, End-Stage | Donor Specific Antibodies
-
University of Colorado, DenverVeloxis PharmaceuticalsTerminatedKidney Transplant RejectionUnited States
-
Chiesi Farmaceutici S.p.A.CompletedOrgan or Tissue Transplant; ComplicationsFrance
-
Simon Tremblay, PharmD, PhDVeloxis PharmaceuticalsUnknown
-
University of Illinois at ChicagoVeloxis PharmaceuticalsCompletedDisorder Related to Renal TransplantationUnited States